kuvura udushya duto duto twa kanseri y'ibihaha

Umuti wa Kanseri y'ibihaha itari mito mito

Aka gatabo karambuye kerekana iterambere rigezweho muri kuvura uburyo bushya bwo kuvura kanseri y'ibihaha. Tuzasuzuma uburyo butandukanye bwo kuvura, harimo kuvura intego, immunotherapie, na chimiotherapie, dutange ubumenyi ku mikorere yabyo, ingaruka zabyo, hamwe nuburyo bukwiye kumwirondoro wabarwayi batandukanye. Wige ibijyanye niterambere ryimiterere yubuvuzi bwa NSCLC nuburyo abashakashatsi bakomeje gukora kuburyo bwiza kandi butari uburozi.

Gusobanukirwa Kanseri y'ibihaha itari ntoya (NSCLC)

NSCLC ni iki?

Kanseri y'ibihaha itari ntoya (NSCLC) igera kuri 85% ya kanseri y'ibihaha. Ni itsinda rya kanseri ikura mu bihaha kandi irangwa no kugaragara kwa selile munsi ya microscope. Kwisuzumisha hakiri kare ningirakamaro kugirango umusaruro uvurwe neza. Icyiciro cya kanseri mugupima kigira ingaruka zikomeye kubyemezo byo kuvura no guhanura. Ikigo cy'ubushakashatsi cya Kanseri ya Shandong Baofa (https://www.baofahospital.com/) ni umuyobozi murwego, atanga ubuvuzi bwuzuye nubushakashatsi muri NSCLC.

Gutegura no Gusuzuma NSCLC

Gutegura neza ni ngombwa muguhitamo inzira nziza ya kuvura uburyo bushya bwo kuvura kanseri y'ibihaha. Ibi birimo ibizamini bitandukanye, birimo amashusho yerekana amashusho (CT, PET), biopsies, hamwe no gupima amaraso. Sisitemu yo kubika TNM ikoreshwa muburyo bwo gutondekanya NSCLC ishingiye ku bunini bwibibyimba (T), uruhare rwa lymph node (N), na metastasis (M). Kumenya hakiri kare, akenshi binyuze mubisuzuma bisanzwe kubantu bafite ibyago byinshi, byongera amahirwe yo kuvurwa neza.

Amahitamo yo kuvura NSCLC

Ubuvuzi bugamije

Ubuvuzi bugamije kwibanda kuri molekile zihariye zigira uruhare mu mikurire ya kanseri. Iyi miti irashobora gukora neza kandi ikagira ingaruka nke ugereranije na chimiotherapie gakondo kubarwayi bamwe. Ingero zirimo EGFR inhibitor (nka gefitinib na erlotinib) hamwe na ALK inhibitor (nka crizotinib). Guhitamo imiti igamije guterwa na mutation yihariye igaragara muri selile ya kanseri.

Immunotherapy

Immunotherapy ikoresha imbaraga z'umubiri z'umubiri zo kurwanya kanseri. Inzitizi za Checkpoint, nka pembrolizumab na nivolumab, zifunga poroteyine zibuza umubiri kwirinda indwara ya kanseri. Iyi miti yerekanye intsinzi idasanzwe mu kuvura NSCLC, cyane cyane ku barwayi bafite biomarkers. Immunotherapy irashobora kugira ingaruka zitandukanye na chimiotherapie, bisaba gukurikiranwa neza nabashinzwe ubuvuzi.

Chimoterapi

Chimoterapi ikoresha imiti yica kanseri. Irashobora gukoreshwa wenyine cyangwa ifatanije nubundi buvuzi. Uburyo butandukanye bwa chimiotherapie burahari, bujyanye nibyifuzo byumurwayi hamwe nicyiciro cya kanseri yabo. Ibiyobyabwenge bikunze gukoreshwa birimo cisplatine, karboplatine, na paclitaxel. Chimiotherapie irashobora kugira ingaruka zikomeye, kandi gucunga izo ngaruka ni igice cyingenzi cyo kuvura.

Ubuvuzi

Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa mu kugabanya ibibyimba, kugabanya ibimenyetso, cyangwa kwirinda kanseri. Ubwoko butandukanye bwimiti ivura imirasire irahari, harimo imirasire yumuriro wo hanze na brachytherapy. Imiti ivura imirasire irashobora kandi kugira ingaruka, ukurikije agace kavurirwamo hamwe na dosiye.

Imiti ivuka nubushakashatsi

Ibigeragezo bya Clinical

Kwitabira ibizamini byamavuriro birashobora gutanga uburyo bushya kuvura uburyo bushya bwo kuvura kanseri y'ibihaha mbere yuko biboneka henshi. Ibi bigeragezo birakurikiranwa neza kandi bigaha abarwayi amahirwe yo kugira uruhare mu iterambere ry’ubuvuzi mugihe bahabwa ubuvuzi bugezweho. Abashakashatsi bo mu kigo cy’ubushakashatsi cya kanseri ya Shandong Baofa bagira uruhare rugaragara mu bigeragezo byinshi by’amavuriro bashakisha uburyo bushya bwo kuvura NSCLC.

Ibinyabuzima byamazi

Amazi ya biopies ni inzira idahwitse yo kumenya no gukurikirana kanseri. Harimo gusesengura icyitegererezo cyamaraso kugirango ikwirakwize ibibyimba ADN (ctDNA), bishobora gutanga ubumenyi bwingenzi muburyo bwa kanseri ya kanseri no kuyobora ibyemezo byo kuvura. Ubu buhanga bugezweho butuma imiti yihariye, igahindura gahunda yo kuvura ishingiye kubyo abarwayi bakeneye.

Guhitamo uburyo bwiza

Ibyiza kuvura uburyo bushya bwo kuvura kanseri y'ibihaha uburyo buratandukanye bitewe nibintu byinshi, harimo icyiciro cya kanseri, ubuzima bwumurwayi muri rusange, ndetse no kuba hari ihinduka ryimiterere yihariye. Itsinda rinyuranye ryaba oncologiste, abaganga, n’abandi bahanga mu by'ubuzima bakunze kugira uruhare mu gutegura gahunda yo kuvura yihariye. Gufungura itumanaho hamwe nubuvuzi bwawe nibyingenzi kugirango umenye neza amahitamo yawe kandi ufate ibyemezo byuzuye.

Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.